Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Melanoma 4Uveal Melanoma 2Sezary Syndrome 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Sarcoma, Kaposi 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Hodgkin Disease 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1AIDS-related Kaposi sarcoma 1

Interventions

Paclitaxel 2nirogacestat 1halofuginone 1etoposide phosphate 1Thalidomide 1Sunitinib 1Semaxinib 1Saquinavir 1Ritonavir 1Peripheral Blood Stem Cell Transplantation 1Nelfinavir 1Interleukin-12 Subunit p35 1Indinavir 1Imatinib Mesylate 1Ifosfamide 1Filgrastim 1Etoposide 1Cidofovir 1Carboplatin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × AIDS-related Kaposi sarcoma × Interleukin-12 Subunit p35 × Clear all
NCT00020449 2013-06-19

Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

National Cancer Institute (NCI)

Phase 2 Completed
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡